19/05/2022
Circulating vaccine-derived poliovirus, nOPV2, Outbreak countries
Afghanistan, Africa, India, Pakistan
Coffee With Polio Experts: Dr Ananda Bandyopadhyay
Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance
In this two-part video series, we chat with Dr Ananda Bandyopadhyay, Deputy Director of Polio Technology, Research & Analytics, BMGF, about the new tool in GPEI’s kit to combat cVDPV2: novel oral polio vaccine type 2 (nOPV2).
Related News
11/03/2024
Women play central, diverse and multifaceted roles in safeguarding children from polio, proving that investments in women’s capacities and skills translate into investments in strengthening health systems.
06/03/2024
A new investment case shows that successful polio transition in the 8 priority countries of the WHO Eastern Mediterranean Region will have a very high return on investment.
19/02/2024
An interview with GPEI experts
26/01/2024
Health leaders call for focused efforts in endemic and most consequential geographies
